CBD Knee Scope Study (CBDS)
Post-operative Pain
About this trial
This is an interventional treatment trial for Post-operative Pain
Eligibility Criteria
Inclusion Criteria: Age 18 or older requiring knee arthroscopy for soft tissue injury, acute or chronic knee injury able to complete surveys and follow-up visits Exclusion Criteria: younger than 18 years of age history of knee dislocation, fracture, previous surgery, coexisting extremity pathology, *pregnancy.
Sites / Locations
- Foundation for Orthopaedic Research and Education/ Florida Orthpaedic Institute
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Standard of Care
Cannabidiol Oil 100 mg/day
Cannabidiol Oil 200 mg/day
Opioid standard of care: Percocet (oxycodone 5mg-acetaminophen 325 mg) every 4 hours PRN postoperatively for 7 days
CDB 100mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively
CBD 200mg PO liquid suspension QD starting 30 days prior to surgery and finishing 30 days post-operatively.